Farther Finance Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,668
Closed -$373K 5804
2025
Q4
$373K Buy
3,668
+2,033
+124% +$163K ﹤0.01% 1503
2025
Q3
$89.5K Buy
1,635
+617
+61% +$30.8K ﹤0.01% 2097
2025
Q2
$54.1K Buy
1,018
+275
+37% +$14K ﹤0.01% 2099
2025
Q1
$32.3K Buy
743
+169
+29% +$8.56K ﹤0.01% 2128
2024
Q4
$32.3K Sell
574
-1,154
-67% -$71.8K ﹤0.01% 1874
2024
Q3
$118K Sell
1,728
-633
-27% -$35.7K ﹤0.01% 1232
2024
Q2
$100K Buy
2,361
+367
+18% +$20.2K ﹤0.01% 1133
2024
Q1
$140K Buy
1,994
+586
+42% +$37.1K 0.01% 825
2023
Q4
$104K Buy
1,408
+464
+49% +$30.4K 0.01% 788
2023
Q3
$64.4K Buy
944
+248
+36% +$21K 0.01% 699
2023
Q2
$65.4K Buy
696
+256
+58% +$20K 0.01% 583
2023
Q1
$29.8K Buy
440
+436
+10,900% +$28K 0.01% 776
2022
Q4
$198 Buy
+4
New +$163 ﹤0.01% 2040

Other funds holding EXAS

Farther Finance Advisors's EXAS Position: Q1 2026 in Review

Farther Finance Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,668 shares — an estimated $373K sold.

Farther Finance Advisors first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $373K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Farther Finance Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 3,668 Exact Sciences shares in Q1 2026, an estimated $373K.
  • Farther Finance Advisors first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Farther Finance Advisors's Exact Sciences position peaked at $373K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.